搜索临床试验以:重组人源化抗PD-1单克隆抗体注射液
总计944个结果
-
Anwita BiosciencesShanghai Junshi Bioscience Co., Ltd.招聘中
-
National Cancer Institute (NCI)完全的
-
Sinocelltech Ltd.Tianjin Medical University Cancer Institute and Hospital未知
-
Roswell Park Cancer InstituteGlaxoSmithKline主动,不招人
-
University of California, IrvineNational Cancer Institute (NCI); National Institutes of Health (NIH)完全的乳腺癌 | HER2阳性乳腺癌 | II期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | IA期乳腺癌 | IB 期乳腺癌 | IIIC期乳腺癌 | 复发性乳腺癌 | HER2 阴性乳腺癌美国
-
National Cancer Institute (NCI)Gynecologic Oncology Group完全的
-
National Cancer Institute (NCI)完全的
-
Sichuan Baili Pharmaceutical Co., Ltd.Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.尚未招聘
-
Changchun BCHT Biotechnology Co.The First Affiliated Hospital of Yunnan University of Traditional Chinese Medicine; Anning City... 和其他合作者尚未招聘
-
National Cancer Institute (NCI)Gynecologic Oncology Group完全的
-
Barbara Ann Karmanos Cancer InstituteGenentech, Inc.完全的
-
Beijing Dongfang Biotech Co., Ltd.Cancer Institute and Hospital, Chinese Academy of Medical Sciences尚未招聘
-
Cancer Institute and Hospital, Chinese Academy...招聘中
-
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.Shandong Cancer Hospital and Institute招聘中
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.暂停
-
Shanghai Henlius Biotech招聘中
-
EVIVE BiotechnologyPeking University Cancer Hospital & Institute未知复发或难治性 B 细胞淋巴瘤
-
Radboud University Medical CenterPfizer; ImaginAb, Inc.; University Hospital Tuebingen尚未招聘
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)终止复发性鳞状细胞肺癌 | 复发性肺腺癌 | IV 期肺腺癌 | 复发性大细胞肺癌 | IV 期鳞状细胞肺癌 | IV 期大细胞肺癌美国, 墨西哥
-
Innovent Biologics (Suzhou) Co. Ltd.终止
-
National Cancer Institute (NCI)NRG Oncology完全的恶性卵巢上皮性肿瘤 | 卵巢两性母细胞瘤 | 卵巢支持间质细胞瘤 | 卵巢性索肿瘤伴环状小管 | 卵巢类固醇细胞瘤 | 卵巢颗粒细胞瘤 | 卵巢性索间质瘤 | 混合或未分类细胞类型的卵巢性索间质瘤美国
-
The Fourth Affiliated Hospital of Zhejiang University...招聘中
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University招聘中
-
National Cancer Institute (NCI)完全的睫状体和脉络膜黑色素瘤,中号/大号 | 睫状体和脉络膜黑色素瘤,小尺寸 | 虹膜黑色素瘤 | 转移性眼内黑色素瘤 | 复发性眼内黑色素瘤 | IV 期眼内黑色素瘤美国